
Trikafta (elexacaftor, tezacaftor, and ivacaftor) is a prescription triple-combination medication used to treat cystic fibrosis (CF).It works by helping the defective CFTR protein function correctly, thereby thinning thick, sticky mucus and improving lung function
Tablet
150 mg per tablet
84 tablets
Store at 68°F to 77°F (20°C to 25°C);
Vertex Pharmaceuticals
Vertex Pharmaceuticals
International pharmaceutical standards compliant with WHO-GMP & GDP regulations
Procured strictly from audited, licensed global manufacturers with batch CoA authentication.
Active temperature logging during air cargo transit (refrigerated 2°C–8°C and CRT 15°C–25°C).
Pre-dispatch inspection, tamper-evident packing, and documentation verified by licensed pharmacists.
Trikafta tablets are used to treat cystic fibrosis (CF)
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Essential information on active composition, WHO-GMP quality compliance, cold-chain storage, and international export.
Trikafta Tablet is a certified pharmaceutical product formulated as a Tablet (150 mg per tablet). It contains the active pharmaceutical ingredient Elexacaftor (100mg) ,Tezacaftor (50mg) and Ivacaftor (75mg) ;(Ivacaftor) 150 mg, manufactured by Vertex Pharmaceuticals.
Trikafta Tablet is manufactured by Vertex Pharmaceuticals complying with strict WHO-GMP / international quality standards. ExSell Laboratories supplies authentic batches accompanied by manufacturer Certificate of Analysis (COA) and complete regulatory documentation.
Trikafta Tablet must be stored according to manufacturer instructions: Store at 68°F to 77°F (20°C to 25°C);. ExSell Laboratories utilizes validated temperature-controlled cold-chain packaging for international transit.
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Browse more WHO-GMP certified formulations from our export catalogue.

Halothane (100%)

Halothane (100%)

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Amoxycillin (500mg) + Clavulanic Acid (125mg)
Trikafta Tablet
150 mg per tablet